These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24831766)

  • 21. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrocortisone reduces restenosis after stenting of small coronary arteries.
    Kakio T; Matsumori A; Ohashi N; Yamada T; Saito T; Kawamoto A; Taguchi A; Morita Y; Takahashi M; Sasayama S
    J Interv Cardiol; 2004 Oct; 17(5):295-300. PubMed ID: 15491332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
    Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.
    Inoue T; Sata M; Hikichi Y; Sohma R; Fukuda D; Uchida T; Shimizu M; Komoda H; Node K
    Circulation; 2007 Feb; 115(5):553-61. PubMed ID: 17261663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
    Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
    Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
    Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
    J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proximal coronary artery intervention: stent thrombosis, restenosis and death.
    Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O
    Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting.
    Dietz U; Holz N; Dauer C; Lambertz H
    Heart; 2006 Jan; 92(1):80-4. PubMed ID: 15883134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S; Yoneda S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Cardiovasc Pathol; 2012; 21(2):e19-22. PubMed ID: 21489821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules.
    Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Driva M; Panagopoulou V; Lappos S; Rentoukas I; Pyrgakis V; Alpert MA
    Am J Cardiol; 2010 Jan; 105(1):54-8. PubMed ID: 20102890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis?
    Ulus T; Yildirir A; Demirtas S; Demir O; Sade LE; Bozbas H; Gürsoy Y; Bilgi M; Küçük MA; Müderrisoğlu H
    Atherosclerosis; 2007 Dec; 195(2):348-53. PubMed ID: 17087967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.
    Ferrante G; Niccoli G; Biasucci LM; Liuzzo G; Burzotta F; Galiuto L; Trani C; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2008; 9(3):156-65. PubMed ID: 18606379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphology and location of restenosis following bare metal coronary stenting.
    Schweiger MJ; Ansari E; Giugliano GR; Mathew J; Islam A; Morrison J; Cook JR
    J Invasive Cardiol; 2006 Apr; 18(4):165-8. PubMed ID: 16729402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery disease.
    Murasaki K; Kawana M; Murasaki S; Tsurumi Y; Tanoue K; Hagiwara N; Kasanuki H
    Heart Vessels; 2007 Jul; 22(4):229-36. PubMed ID: 17653516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting.
    Matsuo Y; Imanishi T; Hayashi Y; Tomobuchi Y; Kubo T; Hano T; Akasaka T
    Intern Med; 2006; 45(9):581-7. PubMed ID: 16755088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of plasma aldosterone levels for prediction of in-stent restenosis.
    Amano T; Matsubara T; Izawa H; Torigoe M; Yoshida T; Hamaguchi Y; Ishii H; Miura M; Hayashi Y; Ogawa Y; Murohara T
    Am J Cardiol; 2006 Mar; 97(6):785-8. PubMed ID: 16516576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.